Bailard’s Biote Corp BTMD Stock Holding History

Bailard’s Portfolio BTMD Stock Details BTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-19,506	Closed	-$146K	–	749
2024 Q2	$146K	Buy	+19,506	New	+$120K	﹤0.01%	701
2024 Q1	–	Sell	-19,500	Closed	-$96.3K	–	741
2023 Q4	$96.3K	Buy	+19,500	New	+$101K	﹤0.01%	695

Other funds holding BTMD

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIM

SW Investment Management Telluride, Colorado $451M AUM 79.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bailard's BTMD Position: Q3 2024 in Review

Bailard sold out of Biote Corp (BTMD) in Q3 2024, closing a stake of 19,506 shares — an estimated $146K sold.

Bailard first reported a position in BTMD in Q4 2023 and held it in 2 quarters. The position peaked at $146K in Q2 2024. 83 funds tracked by Wall St. Rank hold BTMD as of Q3 2024.

Bailard reported no remaining Biote Corp position as of Q3 2024 after selling out during the quarter.
Bailard sold 19,506 Biote Corp shares in Q3 2024, an estimated $146K.
Bailard first reported a position in Biote Corp in Q4 2023 and held it in 2 quarters.
Bailard's Biote Corp position peaked at $146K in Q2 2024.
83 funds tracked by Wall St. Rank held Biote Corp as of Q3 2024.

Based on Bailard's 13F filing for Q3 2024, filed 30 Oct 2024.